Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation

Xiaohui Duan, Weihong Gu, Christopher Jon Klein, Ying Hao, Guoxiang Wang, Renbin Wang, Dongsheng Fan

Research output: Contribution to journalArticle

Abstract

Objective: To investigate the characteristics of mitofusin2 (MFN2) mutation and the clinical variability of Charcot-Marie-Tooth disease type 2 (CMT2) patients. Methods: MFN2 mutation analysis were performed in 8 autosomal dominant CMT2 families and 24 sporadic CMT2 cases by PCR and direct sequencing. The clinical features of the positive cases were precisely analyzed. Results: Sequencing of the MFN2 gene revealed 4 different missense mutations, and detection rate was 4 of 32 (12.5%) in patients with CMT2. c. 281G≤A (R94Q) and c. 2240 T≤C (M747T) were detected in 2 autosomal dominant pedigrees, and intrafamilial clinical phenotype variability was present; c. 1090 C≤T (R364W)and c. 2198 T≤C (1.733P) were detected in 2 sporadic cases, and the latter was a novel mutation which had not been reported. In addition to weakness and atrophy in the distal limbs, the former sporadic case was optic atrophy, and the latter case was hyperkeratosis of the skin. Conclusions: Divergent MFN2 mutations are frequently found among axonal varieties of CMT2 in the Chinese population, and analysis of phenotypes in the CMT2A2 patients indicate the high clinical variability of this disease.

Original languageEnglish (US)
Pages (from-to)77-83
Number of pages7
JournalChinese Journal of Neurology
Volume47
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Charcot-Marie-Tooth Disease
Phenotype
Mutation
Optic Atrophy
Mutation Rate
Missense Mutation
Pedigree
Atrophy
Extremities
Polymerase Chain Reaction
Skin
Population
Genes

Keywords

  • Charcot-Marie-Tooth disease
  • Mitochondrial proteins
  • Mutation
  • Phenotype

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation. / Duan, Xiaohui; Gu, Weihong; Klein, Christopher Jon; Hao, Ying; Wang, Guoxiang; Wang, Renbin; Fan, Dongsheng.

In: Chinese Journal of Neurology, Vol. 47, No. 2, 2014, p. 77-83.

Research output: Contribution to journalArticle

Duan, Xiaohui ; Gu, Weihong ; Klein, Christopher Jon ; Hao, Ying ; Wang, Guoxiang ; Wang, Renbin ; Fan, Dongsheng. / Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation. In: Chinese Journal of Neurology. 2014 ; Vol. 47, No. 2. pp. 77-83.
@article{6f9053f658084795bb6fffcf64f9cb51,
title = "Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation",
abstract = "Objective: To investigate the characteristics of mitofusin2 (MFN2) mutation and the clinical variability of Charcot-Marie-Tooth disease type 2 (CMT2) patients. Methods: MFN2 mutation analysis were performed in 8 autosomal dominant CMT2 families and 24 sporadic CMT2 cases by PCR and direct sequencing. The clinical features of the positive cases were precisely analyzed. Results: Sequencing of the MFN2 gene revealed 4 different missense mutations, and detection rate was 4 of 32 (12.5{\%}) in patients with CMT2. c. 281G≤A (R94Q) and c. 2240 T≤C (M747T) were detected in 2 autosomal dominant pedigrees, and intrafamilial clinical phenotype variability was present; c. 1090 C≤T (R364W)and c. 2198 T≤C (1.733P) were detected in 2 sporadic cases, and the latter was a novel mutation which had not been reported. In addition to weakness and atrophy in the distal limbs, the former sporadic case was optic atrophy, and the latter case was hyperkeratosis of the skin. Conclusions: Divergent MFN2 mutations are frequently found among axonal varieties of CMT2 in the Chinese population, and analysis of phenotypes in the CMT2A2 patients indicate the high clinical variability of this disease.",
keywords = "Charcot-Marie-Tooth disease, Mitochondrial proteins, Mutation, Phenotype",
author = "Xiaohui Duan and Weihong Gu and Klein, {Christopher Jon} and Ying Hao and Guoxiang Wang and Renbin Wang and Dongsheng Fan",
year = "2014",
doi = "10.3760/cma.j.issn.1006-7876.2014.02.003",
language = "English (US)",
volume = "47",
pages = "77--83",
journal = "Chinese Journal of Neurology",
issn = "1006-7876",
publisher = "Chinese Medical Association",
number = "2",

}

TY - JOUR

T1 - Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation

AU - Duan, Xiaohui

AU - Gu, Weihong

AU - Klein, Christopher Jon

AU - Hao, Ying

AU - Wang, Guoxiang

AU - Wang, Renbin

AU - Fan, Dongsheng

PY - 2014

Y1 - 2014

N2 - Objective: To investigate the characteristics of mitofusin2 (MFN2) mutation and the clinical variability of Charcot-Marie-Tooth disease type 2 (CMT2) patients. Methods: MFN2 mutation analysis were performed in 8 autosomal dominant CMT2 families and 24 sporadic CMT2 cases by PCR and direct sequencing. The clinical features of the positive cases were precisely analyzed. Results: Sequencing of the MFN2 gene revealed 4 different missense mutations, and detection rate was 4 of 32 (12.5%) in patients with CMT2. c. 281G≤A (R94Q) and c. 2240 T≤C (M747T) were detected in 2 autosomal dominant pedigrees, and intrafamilial clinical phenotype variability was present; c. 1090 C≤T (R364W)and c. 2198 T≤C (1.733P) were detected in 2 sporadic cases, and the latter was a novel mutation which had not been reported. In addition to weakness and atrophy in the distal limbs, the former sporadic case was optic atrophy, and the latter case was hyperkeratosis of the skin. Conclusions: Divergent MFN2 mutations are frequently found among axonal varieties of CMT2 in the Chinese population, and analysis of phenotypes in the CMT2A2 patients indicate the high clinical variability of this disease.

AB - Objective: To investigate the characteristics of mitofusin2 (MFN2) mutation and the clinical variability of Charcot-Marie-Tooth disease type 2 (CMT2) patients. Methods: MFN2 mutation analysis were performed in 8 autosomal dominant CMT2 families and 24 sporadic CMT2 cases by PCR and direct sequencing. The clinical features of the positive cases were precisely analyzed. Results: Sequencing of the MFN2 gene revealed 4 different missense mutations, and detection rate was 4 of 32 (12.5%) in patients with CMT2. c. 281G≤A (R94Q) and c. 2240 T≤C (M747T) were detected in 2 autosomal dominant pedigrees, and intrafamilial clinical phenotype variability was present; c. 1090 C≤T (R364W)and c. 2198 T≤C (1.733P) were detected in 2 sporadic cases, and the latter was a novel mutation which had not been reported. In addition to weakness and atrophy in the distal limbs, the former sporadic case was optic atrophy, and the latter case was hyperkeratosis of the skin. Conclusions: Divergent MFN2 mutations are frequently found among axonal varieties of CMT2 in the Chinese population, and analysis of phenotypes in the CMT2A2 patients indicate the high clinical variability of this disease.

KW - Charcot-Marie-Tooth disease

KW - Mitochondrial proteins

KW - Mutation

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=84898849189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898849189&partnerID=8YFLogxK

U2 - 10.3760/cma.j.issn.1006-7876.2014.02.003

DO - 10.3760/cma.j.issn.1006-7876.2014.02.003

M3 - Article

AN - SCOPUS:84898849189

VL - 47

SP - 77

EP - 83

JO - Chinese Journal of Neurology

JF - Chinese Journal of Neurology

SN - 1006-7876

IS - 2

ER -